DOI QR코드

DOI QR Code

Anti-Inflammatory Effect of Asterias amurensis Fatty Acids through NF-κB and MAPK Pathways against LPS-Stimulated RAW264.7 Cells

  • Monmai, Chaiwat (Department of Marine Food Science and Technology, Gangneung-Wonju National University) ;
  • Go, Seok Hyeon (Department of Marine Food Science and Technology, Gangneung-Wonju National University) ;
  • Shin, Il-sik (Department of Marine Food Science and Technology, Gangneung-Wonju National University) ;
  • You, SangGuan (Department of Marine Food Science and Technology, Gangneung-Wonju National University) ;
  • Kim, Dae-ok (Department of Food Science and Biotechnology, Kyung Hee University) ;
  • Kang, SeokBeom (Citrus Research Station, National Institute of Horticultural and Herbal Science, RDA) ;
  • Park, Woo Jung (Department of Marine Food Science and Technology, Gangneung-Wonju National University)
  • Received : 2018.03.28
  • Accepted : 2018.08.22
  • Published : 2018.10.28

Abstract

Asterias amurensis (starfish) is a marine organism that is harmful to the fishing industry, but is also a potential source of functional materials. The present study was conducted to analyze the profiles of fatty acids extracted from A. amurensis tissues and their anti-inflammatory effects on RAW264.7 macrophage cells. In different tissues, the component ratios of saturated fatty acids, monounsaturated fatty acids, and polyunsaturated fatty acids differed; particularly, polyunsaturated fatty acids such as dihomo-gamma-linolenic acid (20:3n-6) and eicosapentaenoic acid (20:5n-3) were considerably different. In lipopolysaccharide-stimulated RAW264.7 cells, fatty acids from A. amurensis skin, gonads, and digestive glands exhibited anti-inflammatory activities by reducing nitric oxide production and inducing nitric oxide synthase gene expression. Asterias amurensis fatty acids effectively suppressed the expression of inflammatory cytokines such as tumor necrosis $factor-{\alpha}$, interleukin-$1{\beta}$, and interleukin-6 in lipopolysaccharide-stimulated cells. Cyclooxygenase-2 and prostaglandin $E_2$, which are critical inflammation biomarkers, were also significantly suppressed. Furthermore, A. amurensis fatty acids reduced the phosphorylation of nuclear $factor-{\kappa}B$ p-65, p38, extracellular signal-related kinase 1/2, and c-Jun N-terminal kinase, indicating that these fatty acids ameliorated inflammation through the nuclear $factor-{\kappa}B$ and mitogen-activated protein kinase pathways. These results provide insight into the anti-inflammatory mechanism of A. amurensis fatty acids on immune cells and suggest that the species is a potential source of anti-inflammatory molecules.

Keywords

References

  1. Roche HM. 1999. Unsaturated fatty acids. Proc. Nutr. Soc. 58: 397-401. https://doi.org/10.1017/S002966519900052X
  2. Ford JH. 2010. Saturated fatty acid metabolism is key link between cell division, cancer, and senescence in cellular and whole organism aging. Age 32: 231-237. https://doi.org/10.1007/s11357-009-9128-x
  3. Volpe JJ, Vagelos PR. 1976. Mechanisms and regulation of biosynthesis of saturated fatty acids. Physiol. Rev. 56: 339-417. https://doi.org/10.1152/physrev.1976.56.2.339
  4. Joris PJ, Mensink RP. 2016. Role of cis-monounsaturated fatty acids in the prevention of coronary heart disease. Curr. Atheroscler. Rep. 18: 38-44. https://doi.org/10.1007/s11883-016-0597-y
  5. Juarez-Hernandez E, Chavez-Tapia NC, Uribe M, Barbero-Becerra VJ. 2016. Role of bioactive fatty acids in nonalcoholic fatty liver disease. Nutr. J. 15: 72-81.
  6. Zock PL, Blom WA, Nettleton JA, Hornstra G. 2016. Progressing insights into the role of dietary fats in the prevention of cardiovascular disease. Curr. Cardiol. Rep. 18: 111-123. https://doi.org/10.1007/s11886-016-0793-y
  7. Gormaz JG, Rodrigo R, Videla LA, Beems M. 2010. Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease. Prog. Lipid Res. 49: 407-419. https://doi.org/10.1016/j.plipres.2010.05.003
  8. Simopoulos AP. 2008. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood) 233: 674-688. https://doi.org/10.3181/0711-MR-311
  9. Superko HR, Superko AR, Lundberg GP, Margolis B, Garrett BC, Nasir K, et al. 2014. Omega-3 fatty acid blood levels clinical significance update. Curr. Cardiovasc. Risk Rep. 8: 407-414. https://doi.org/10.1007/s12170-014-0407-4
  10. Fasano E, Serini S, Cittadini A, Calviello G. 2017. Long-chain n-3 PUFA against breast and prostate cancer: which are the appropriate doses for intervention studies in animals and humans? Crit. Rev. Food Sci. Nutr. 57: 2245-2262. https://doi.org/10.1080/10408398.2013.850060
  11. Zheng JS, Huang T, Yang J, Fu YQ, Li D. 2012. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One 7: e44525-44538. https://doi.org/10.1371/journal.pone.0044525
  12. Massey KA, Nicolaou A. 2011. Lipidomics of polyunsaturated-fatty-acid-derived oxygenated metabolites. Biochem. Soc. Trans. 39: 1240-1246. https://doi.org/10.1042/BST0391240
  13. Nicolaou A. 2013. Eicosanoids in skin inflammation. Prostaglandins Leukot. Essent. Fatty Acids 88: 131-138. https://doi.org/10.1016/j.plefa.2012.03.009
  14. Wolfe LS. 1982. Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J. Neurochem. 38: 1-14. https://doi.org/10.1111/j.1471-4159.1982.tb10847.x
  15. Calder PC. 2013. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br. J. Clin. Pharmacol. 75: 645-662. https://doi.org/10.1111/j.1365-2125.2012.04374.x
  16. Davidson J, Rotondo D, Rizzo MT, Leaver HA. 2012. Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolism. Br. J. Pharmacol. 166: 1193-1210. https://doi.org/10.1111/j.1476-5381.2012.01900.x
  17. Greene ER, Huang S, Serhan CN, Panigrahy D. 2011. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 96: 27-36. https://doi.org/10.1016/j.prostaglandins.2011.08.004
  18. Shah AK, Kinoshita M, Kurihara H, Ohnishi M, Takahashi K. 2008. Glycosylceramides obtain from the starfish Asterias amurensis Lutken. J. Oleo Sci. 57: 477-484. https://doi.org/10.5650/jos.57.477
  19. Dong G, Xu T, Yang B, Lin X, Zhou X, Yang X, et al. 2011 . Chemical constituents and bioactivities of starfish. Chem. Biodivers. 8: 740-791. https://doi.org/10.1002/cbdv.200900344
  20. D'Orazio N, Gammone MA, Gemello E, De Girolamo M, Cusenza S, Riccioni G. 2012. Marine bioactives: pharmacological properties and potential applications against inflammatory diseases. Marine Drugs 10: 812-833. https://doi.org/10.3390/md10040812
  21. Mayer AM, Hamann MT. 2005. Marine pharmacology in 2001-2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 140: 265-286. https://doi.org/10.1016/j.cca.2005.04.004
  22. Higuchi R, Inoue S, Inagaki K, Sakai M, Miyamoto T, Komori T, et al. 2006. Biologically active glycosides from asteroidea, 42. Isolation and structure of a new biologically active ganglioside molecular species from the starfish Asterina pectinifera. Chem. Pharm. Bull. 54: 287-291. https://doi.org/10.1248/cpb.54.287
  23. Han YH, Ham JH, Lee NJ, Park CH, Shin YH, Lee DU. 2000. Antimutagenic activity of 5alpha-cholest-7-en-3beta-ol, a new component from the starfish Asterina pectinifera. Biol. Pharm. Bull. 23: 1247-1249. https://doi.org/10.1248/bpb.23.1247
  24. Peng Y, Zheng J, Huang R, Wang Y, Xu T, Zhou X, et al. 2010. Polyhydroxy steroids and saponins from China Sea starfish Asterina pectinifera and their biological activities. Chem. Pharm. Bull. (Tokyo) 58: 856-858. https://doi.org/10.1248/cpb.58.856
  25. Hossain Z, Kurihara H, Hosokawa M, Takahashi K. 2006. Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells. Mol. Cell Biochem. 285: 155-163. https://doi.org/10.1007/s11010-005-9074-6
  26. Garces R, Mancha M. 1993. One-step lipid extraction and fatty acid methyl esters preparation from fresh plant tissues. Anal. Biochem. 211: 139-143. https://doi.org/10.1006/abio.1993.1244
  27. Park WJ, Kothapalli KS, Lawrence P, Tyburczy C, Brenna JT. 2009. An alternate pathway to long-chain polyunsaturates: the FADS2 gene product Delta8-desaturates 20:2n-6 and 20:3n-3. J. Lipid Res. 50: 1195-1202. https://doi.org/10.1194/jlr.M800630-JLR200
  28. Kim JK, Cho ML, Karnjanapratum S, Shin IS, You SG. 2011. In vitro and in vivo immunomodulatory activity of sulfated polysaccharides from Enteromorpha prolifera. Int. J. Biol. Macromol. 49: 1051-1508. https://doi.org/10.1016/j.ijbiomac.2011.08.032
  29. Cao RA, Lee Y, You S. 2014. Water soluble sulfated-fucans with immune-enhancing properties from Ecklonia cava. Int. J. Biol. Macromol. 67: 303-311. https://doi.org/10.1016/j.ijbiomac.2014.03.019
  30. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138. https://doi.org/10.1016/0003-2697(82)90118-X
  31. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. https://doi.org/10.1006/meth.2001.1262
  32. Narayanan BA, Narayanan NK, Simi B, Reddy BS. 2003. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res. 63: 972-979.
  33. Lechner M, Lirk P, Rieder J. 2005. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin. Cancer Biol. 15: 277-289. https://doi.org/10.1016/j.semcancer.2005.04.004
  34. Pereira DM, Correia-da-Silva G, Valentao P, Teixeira N, Andrade PB. 2014. Anti-inflammatory effect of unsaturated fatty acids and Ergosta-7,22-dien-3-ol from Marthasterias glacialis: prevention of CHOP-mediated ER-stress and NF-kappaB activation. PLoS One 9: e88341-88349. https://doi.org/10.1371/journal.pone.0088341
  35. Carten JD, Bradford MK, Farber SA. 2011. Visualizing digestive organ morphology and function using differential fatty acid metabolism in live zebrafish. Dev. Biol. 360: 276-285. https://doi.org/10.1016/j.ydbio.2011.09.010
  36. Olefsky JM, Glass CK. 2010. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72: 219-246. https://doi.org/10.1146/annurev-physiol-021909-135846
  37. Hu SS, Bradshaw HB, Chen JS, Tan B, Walker JM. 2008. Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. Br. J. Pharmacol. 153: 1538-1549.
  38. Ya Z, Jianxing L, Chunping L, Xing Z, Xiong L, Zhao J. 2016. Anti-inflammatory effects of p-coumaric acid in LPS-stimulated RAW264.7 cells: involvement of $NF-{\kappa}B$ and MAPKs pathways. J. Med. Chem. 6: 327-330.
  39. Tak PP, Firestein GS. 2001 . NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107: 7-11. https://doi.org/10.1172/JCI11830
  40. Baeuerle PA, Baltimore D. 1996. NF-kappa B: ten years after. Cell 87: 13-20. https://doi.org/10.1016/S0092-8674(00)81318-5
  41. Kim JB, Han AR, Park EY, Kim JY, Cho W, Lee J, et al. 2007. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappaB inactivation in RAW 264.7 macrophage cells. Biol. Pharm. Bull. 30: 2345-2351. https://doi.org/10.1248/bpb.30.2345
  42. Cargnello M, Roux PP. 2011. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75: 50-83. https://doi.org/10.1128/MMBR.00031-10
  43. Li YY, Hsieh LL, Tang RP, Liao SK, Yeh KY. 2009. Interleukin-6 (IL-6) released by macrophages induces IL-6 secretion in the human colon cancer HT-29 cell line. Hum. Immunol. 70: 151-158. https://doi.org/10.1016/j.humimm.2009.01.004

Cited by

  1. Walnut-Associated Fatty Acids Inhibit LPS-Induced Activation of BV-2 Microglia vol.43, pp.1, 2020, https://doi.org/10.1007/s10753-019-01113-y
  2. 열처리 불가사리 추출물의 항염 활성 vol.30, pp.7, 2018, https://doi.org/10.5352/jls.2020.30.7.634
  3. The therapeutic effect of PEGlated nanoliposome of pistachio unsaturated oils and its efficacy to attenuate inflammation in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical vol.362, pp.None, 2018, https://doi.org/10.1016/j.jneuroim.2021.577768